Dimitar Kalev

506 total citations
3 papers, 47 citations indexed

About

Dimitar Kalev is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Dimitar Kalev has authored 3 papers receiving a total of 47 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Pulmonary and Respiratory Medicine, 2 papers in Oncology and 1 paper in Surgery. Recurrent topics in Dimitar Kalev's work include Advanced Breast Cancer Therapies (1 paper), Bone health and treatments (1 paper) and Radiopharmaceutical Chemistry and Applications (1 paper). Dimitar Kalev is often cited by papers focused on Advanced Breast Cancer Therapies (1 paper), Bone health and treatments (1 paper) and Radiopharmaceutical Chemistry and Applications (1 paper). Dimitar Kalev collaborates with scholars based in United States, Netherlands and Bulgaria. Dimitar Kalev's co-authors include Daniel Egle, Eva Ciruelos, Mona El-Hashimy, Wolfgang Janni, Alessio Schirone, Sibel Blau, Bharani Dharan, Ruth O’Regan, Roberto Bordonaro and Denis Weber and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and memo - Magazine of European Medical Oncology.

In The Last Decade

Dimitar Kalev

3 papers receiving 47 citations

Peers

Countries citing papers authored by Dimitar Kalev

Since Specialization

Citations

This map shows the geographic impact of Dimitar Kalev's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dimitar Kalev with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dimitar Kalev more than expected).

Fields of papers citing papers by Dimitar Kalev

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dimitar Kalev. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dimitar Kalev. The network helps show where Dimitar Kalev may publish in the future.

Co-authorship network of co-authors of Dimitar Kalev

This figure shows the co-authorship network connecting the top 25 collaborators of Dimitar Kalev. A scholar is included among the top collaborators of Dimitar Kalev based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dimitar Kalev. Dimitar Kalev is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

3 of 3 papers shown

#	Work	Indexed citations
1	A phase II, randomized, double-blind, placebo-controlled trial evaluating efficacy and safety of namodenoson (CF102), an A₃ adenosine receptor agonist (A₃AR), as a second-line treatment in patients with Child-Pugh B (CPB) advanced hepatocellular carcinoma (HCC). 2019 ·Journal of Clinical Oncology ·Salomon M. Stemmer, Nebojša Manojlović, Mihai Vasile Marinca, Petar Petrov, (unknown), Doina Ganea, Tudor–Eliade Ciuleanu, (unknown), Muhammad Shaalan Beg, W. Thomas Purcell, (unknown), Rumyana Ilieva, (unknown), (unknown), Dimitar Kalev, (unknown), Motti Farbstein, Michael H. Silverman, Pnina Fishman, Josep M. Llovet	8
2	Abstract S4-07: BELLE-3: A phase III study of buparlisib + fulvestrant in postmenopausal women with HR+, HER2–, aromatase inhibitor-treated, locally advanced or metastatic breast cancer, who progressed on or after mTOR inhibitor-based treatment 2017 ·Cancer Research ·Angelo Di Leo, Keun Seok Lee, Eva Ciruelos, Per Eystein Lønning, Wolfgang Janni, Ruth O’Regan, (unknown), Dimitar Kalev, Daniel Egle, Tibor Csőszi, Roberto Bordonaro, Thomas Decker, (unknown), Sibel Blau, Alessio Schirone, Denis Weber, Mona El-Hashimy, Bharani Dharan, Dalila Sellami, Thomas Bachelot	38
3	CECOG experts’ recommendations on the use of denosumab in the prevention of skeletal-related events in bone metastases of lung cancer 2013 ·memo - Magazine of European Medical Oncology ·Wolfgang Hilbe, Ufuk Abacıoğlu, Daniel M. Aebersold, M. Bachouchi, Thomas Brodowicz, Rabab Gaafar, Gerold Holzer, Andrea Mohn-Staudner, Dimitar Kalev, Ewa Kalinka‐Warzocha, Viljem Kovač, Marco Siano, Perran Fulden Yumuk, Lilla Tamási	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact